{"id": "F5.2-000167-S1-P2", "question": "Show drugs with variant-based evidence in Chronic Myelogenous Leukaemia.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'chronic' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('dasatinib') OR\n  toLower(t.name) = toLower('nilotinib') OR\n  toLower(t.name) = toLower('bosutinib') OR\n  toLower(t.name) = toLower('ponatinib') OR\n  toLower(t.name) = toLower('imatinib') OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('dasatinib')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('nilotinib')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('bosutinib')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('ponatinib')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('imatinib'))\n)\nAND toLower(rel.disease_name) CONTAINS toLower('chronic myelogenous leukaemia')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL OR variant_name IS NOT NULL\nWITH\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  collect(pmids) AS pmid_lists\nWITH\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  reduce(allp = [], lst IN pmid_lists | allp + lst) AS pmids\nRETURN\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ABL1 T315I", "gene_symbol": "ABL1", "therapy_name": "Asciminib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["31826340"]}, {"variant_name": "BCR BCR::ABL1 Fusion", "gene_symbol": "BCR", "therapy_name": "Asciminib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["38820078"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 D276G", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255K", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255V AND ABL1 V299L", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E279K", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E292L", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317L", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317L AND ABL1 F359V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317R", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359V AND ABL1 V299L", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F486S", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 G250E", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396P", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396R", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L248R", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L248R AND ABL1 F359I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L248V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L384M", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M244V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M343T", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M351T", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M351T AND ABL1 V299L", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Q252H", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315A", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603", "26912052", "26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I AND ABL1 E255V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I AND ABL1 F359V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I AND ABL1 G250E", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I AND ABL1 H396R", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I AND ABL1 M244V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I AND ABL1 Y253H", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315L", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315M", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 V299L", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Y253F", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["25686603"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Y253H", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Y253H AND ABL1 E255V", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}, {"variant_name": "LYN Y508F", "gene_symbol": "LYN", "therapy_name": "Axitinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26912052"]}, {"variant_name": "BCR BCR::ABL1 Fusion", "gene_symbol": "BCR", "therapy_name": "Bafetinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["18191450"]}, {"variant_name": "LYN OVEREXPRESSION", "gene_symbol": "LYN", "therapy_name": "Bafetinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["18191450"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Bafetinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["18191450"]}, {"variant_name": "ABL1 F486Y", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "19075254"]}, {"variant_name": "ABL1 L298V", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "ABL1 Non-P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "22371878"]}, {"variant_name": "ABL1 TKD Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["29091516"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 D276G", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 D276G", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 D421G", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255K", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255V", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E255V", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E279K", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E355G", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E450V", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E453A", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E453K", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 E453Q", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311I", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311L", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317L", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F317L", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359C", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359I", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359V", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F359V", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F486S", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 G250E", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 G250E", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 G398R", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396P", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396P", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396R", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 H396R", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 I432T", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L248V", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L364P", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L384M", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L387F", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 L387F", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M244V", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 M351T", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "22371878", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 N331S", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 N331S", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 N336S", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 P480A", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Q252H", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Q252H", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19039322"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 Q300R", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 T315I", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "19075254"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 TKD Mutation", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 V299L", "gene_symbol": "BCR", "therapy_name": "Bosutinib", "effect": "sensitivity", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "19075254"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000092-P3", "question": "List treatments supported by variant evidence in B-lymphoblastic Leukemia/lymphoma With TCF3-PBX1.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'b-lymphoblastic' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia/lymphoma' AND\n    toLower(rel.disease_name) CONTAINS 'with' AND\n    toLower(rel.disease_name) CONTAINS 'tcf3-pbx1'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (toLower(t.name) CONTAINS toLower('treatment') OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) CONTAINS toLower('treatment')))\nAND toLower(rel.disease_name) CONTAINS toLower('b-lymphoblastic leukemia/lymphoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWHERE (b:Variant AND (toLower(b.name) CONTAINS toLower('tcf3-pbx1') OR any(s IN coalesce(b.synonyms, []) WHERE toLower(s) CONTAINS toLower('tcf3-pbx1')) OR toLower(b.hgvs_p) CONTAINS toLower('p.tcf3-pbx1')))\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "TCF3 TCF3::PBX1 Fusion", "gene_symbol": "TCF3", "therapy_name": "HyperCVAD Regimen", "effect": "sensitivity", "disease_name": "B-lymphoblastic Leukemia/lymphoma With TCF3-PBX1", "pmids": ["32955970"]}, {"variant_name": "TCF3 TCF3::PBX1 Fusion", "gene_symbol": "TCF3", "therapy_name": "NCT00137111", "effect": "sensitivity", "disease_name": "B-lymphoblastic Leukemia/lymphoma With TCF3-PBX1", "pmids": ["19282835"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000096-S1-P1", "question": "Which therapies have variant biomarkers in Carcinoma Of Urinary Bladder?", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'bladder' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('gemcitabine') OR\n  toLower(t.name) = toLower('cisplatin') OR\n  toLower(t.name) = toLower('carboplatin') OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('gemcitabine')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('cisplatin')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('carboplatin'))\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND toLower(rel.disease_name) CONTAINS toLower('urinary bladder')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL OR variant_name IS NOT NULL\nWITH\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  collect(pmids) AS pmid_lists\nWITH\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  reduce(allp = [], lst IN pmid_lists | allp + lst) AS pmids\nRETURN\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": "CD274 Expression", "gene_symbol": "CD274", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["29268948"]}, {"variant_name": "RAF1 Amplification", "gene_symbol": "RAF1", "therapy_name": "B-Raf/VEGFR-2 Inhibitor RAF265", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["34554931"]}, {"variant_name": "ERBB2 D769H", "gene_symbol": "ERBB2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERBB2 R678L", "gene_symbol": "ERBB2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERBB2 S310F", "gene_symbol": "ERBB2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERBB2 S310F AND NOT ERBB2 T306M", "gene_symbol": "ERBB2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERBB2 V777M", "gene_symbol": "ERBB2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERBB2 V842I", "gene_symbol": "ERBB2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERCC2 D257N", "gene_symbol": "ERCC2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERCC2 E86Q", "gene_symbol": "ERCC2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERCC2 N238S", "gene_symbol": "ERCC2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERCC2 S44L", "gene_symbol": "ERCC2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERCC2 T484M", "gene_symbol": "ERCC2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERCC2 Y72C", "gene_symbol": "ERCC2", "therapy_name": "Chemotherapy", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "ERCC1 Expression", "gene_symbol": "ERCC1", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["26162296"]}, {"variant_name": "FGFR1 Expression", "gene_symbol": "FGFR1", "therapy_name": "Dovitinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["21119661"]}, {"variant_name": "FGFR3 Overexpression", "gene_symbol": "FGFR3", "therapy_name": "Dovitinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["21119661"]}, {"variant_name": "FGFR2 FGFR2::? Fusion", "gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["31088831"]}, {"variant_name": "FGFR2 FGFR2::v Fusion", "gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["31340094"]}, {"variant_name": "FGFR3 FGFR3::v Fusion", "gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["31340094"]}, {"variant_name": "FGFR3 FGFR3::v Fusion", "gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["31088831"]}, {"variant_name": "FGFR3 Mutation", "gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["31088831"]}, {"variant_name": "FGFR3 S249C AND FGFR3 R248C AND FGFR3 Y373C AND FGFR3 G370C", "gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["31340094"]}, {"variant_name": "MTOR Mutation", "gene_symbol": "MTOR", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["24625776"]}, {"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "resistance", "disease_name": "Bladder Carcinoma", "pmids": ["23989949"]}, {"variant_name": "TSC1 Frameshift Truncation", "gene_symbol": "TSC1", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Invasive Bladder Transitional Cell Carcinoma", "pmids": ["22923433"]}, {"variant_name": "TSC1 Loss-of-function", "gene_symbol": "TSC1", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["22923433"]}, {"variant_name": "CDKN2A Loss", "gene_symbol": "CDKN2A", "therapy_name": "Immune Checkpoint Inhibitor", "effect": "resistance", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["34074656"]}, {"variant_name": "FGFR1 Amplification", "gene_symbol": "FGFR1", "therapy_name": "Infigratinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["27870574"]}, {"variant_name": "FGFR3 Mutation", "gene_symbol": "FGFR3", "therapy_name": "Infigratinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["27870574"]}, {"variant_name": "FGFR3 R248C", "gene_symbol": "FGFR3", "therapy_name": "Infigratinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["27870574"]}, {"variant_name": "ERBB2 D277H", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["24971884"]}, {"variant_name": "ERBB2 L15F", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["24971884"]}, {"variant_name": "ERBB2 R143Q", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["24971884"]}, {"variant_name": "ERBB2 R678Q", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["24971884"]}, {"variant_name": "ERBB2 S310F", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["24971884"]}, {"variant_name": "ERBB2 S653C", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["24971884"]}, {"variant_name": "TP53 R280T", "gene_symbol": "TP53", "therapy_name": "MDM2 Inhibitor AMGMDS3", "effect": "resistance", "disease_name": "Bladder Carcinoma", "pmids": ["25730903"]}, {"variant_name": "FGFR1 Expression", "gene_symbol": "FGFR1", "therapy_name": "PD173074", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["21119661"]}, {"variant_name": "FGFR3 FGFR3::BAIAP2L1 Fusion", "gene_symbol": "FGFR3", "therapy_name": "PD173074", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["23558953"]}, {"variant_name": "FGFR3 Overexpression", "gene_symbol": "FGFR3", "therapy_name": "PD173074", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["21119661"]}, {"variant_name": "MTOR Mutation", "gene_symbol": "MTOR", "therapy_name": "Pazopanib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["24625776"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Pertuzumab", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["29320312"]}, {"variant_name": "ERBB2 Mutation", "gene_symbol": "ERBB2", "therapy_name": "Platinum Compound", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["25636205"]}, {"variant_name": "FGFR3 S249C", "gene_symbol": "FGFR3", "therapy_name": "R3Mab", "effect": "resistance", "disease_name": "Bladder Carcinoma", "pmids": ["19381019"]}, {"variant_name": "HRAS Mutation", "gene_symbol": "HRAS", "therapy_name": "Tipifarnib", "effect": "sensitivity", "disease_name": "Bladder Urothelial Carcinoma", "pmids": ["32636318"]}, {"variant_name": "RAF1 Amplification", "gene_symbol": "RAF1", "therapy_name": "Trametinib", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["34554931"]}, {"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Trastuzumab", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["29320312"]}, {"variant_name": "FGFR3 Overexpression", "gene_symbol": "FGFR3", "therapy_name": "Tyrosine Kinase Inhibitor SU5402", "effect": "sensitivity", "disease_name": "Bladder Carcinoma", "pmids": ["21119661"]}], "generated_rows": [{"variant_name": "FGFR3 Mutation", "gene_symbol": "FGFR3", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "Urinary Bladder Cancer", "pmids": ["29941343"]}, {"variant_name": "FGFR3 Mutation", "gene_symbol": "FGFR3", "therapy_name": "Gemcitabine", "effect": "sensitivity", "disease_name": "Urinary Bladder Cancer", "pmids": ["29941343"]}], "error": null}
{"id": "F5.2-000170-S1-P1", "question": "Which therapies have variant biomarkers in Vulvar Epidermoid Carcinoma?", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'vulva' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('nivolumab') OR\n  toLower(t.name) = toLower('pembrolizumab') OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('nivolumab')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('pembrolizumab')) OR\n  toLower(t.name) CONTAINS toLower('nivolumab') OR\n  toLower(t.name) CONTAINS toLower('pembrolizumab')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND toLower(rel.disease_name) CONTAINS toLower('vulvar')\nAND toLower(rel.disease_name) CONTAINS toLower('epidermoid carcinoma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "TP53 R158H", "gene_symbol": "TP53", "therapy_name": "MDM2 Inhibitor AMGMDS3", "effect": "resistance", "disease_name": "Vulva Squamous Cell Carcinoma", "pmids": ["25730903"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000093-P3", "question": "List treatments supported by variant evidence in Myofibroma.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'myofibroma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('tamoxifen') OR\n  toLower(t.name) = toLower('fulvestrant') OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('tamoxifen')) OR\n  any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('fulvestrant')) OR\n  toLower(t.name) CONTAINS toLower('tamoxifen') OR\n  toLower(t.name) CONTAINS toLower('fulvestrant')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND toLower(rel.disease_name) CONTAINS toLower('myofibroma')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "TPM3 TPM3::NTRK1 Fusion", "gene_symbol": "TPM3", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Myofibroma", "pmids": ["35395680"]}], "generated_rows": [], "error": null}
{"id": "F5.2-000048-S1", "question": "List therapies with variant-level biomarkers in Minimally Invasive Lung Adenocarcinoma.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'bronchiolo-alveolar' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Variant)-[:VARIANT_OF]->(g:Gene), (b)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('osimertinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('osimertinib'))\n)\nAND toLower(rel.disease_name) CONTAINS toLower('lung')\nRETURN\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) END AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "gold_rows": [{"variant_name": "EGFR E746_A750del", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Bronchiolo-alveolar Adenocarcinoma", "pmids": ["15329413"]}], "generated_rows": [{"variant_name": "BRAF V600E AND EGFR L858R AND EGFR T790M", "gene_symbol": "BRAF", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["29074209"]}, {"variant_name": "EGFR A763_Y764insFQEA", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31208370"]}, {"variant_name": "EGFR A767_V769dupASV", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31208370"]}, {"variant_name": "EGFR Alteration", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37481710"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28202511"]}, {"variant_name": "EGFR C797G", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25939061"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR D770_N771insG", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31208370"]}, {"variant_name": "EGFR EGFR::ERBB4 Fusion", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["39637337"]}, {"variant_name": "EGFR EGFR::RAD51 Fusion", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["38525318"]}, {"variant_name": "EGFR Exon 19 Deletion AND MET Y1003N", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["36188633"]}, {"variant_name": "EGFR Exon 20 Insertion", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31208370"]}, {"variant_name": "EGFR G719", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31825714"]}, {"variant_name": "EGFR L718Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR L718Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR L718Q AND EGFR L718V", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR L718V", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR L792H", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["32193290"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24893891"]}, {"variant_name": "EGFR L858R AND EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27959700"]}, {"variant_name": "EGFR L858R AND EGFR T790M AND VOPP1::EGFR Fusion", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["35004270"]}, {"variant_name": "EGFR L858R OR EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["38828946"]}, {"variant_name": "EGFR L861Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31825714"]}, {"variant_name": "EGFR M766Q", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31254668"]}, {"variant_name": "EGFR N771_P772insL", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31208370"]}, {"variant_name": "EGFR S768I", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31825714"]}, {"variant_name": "EGFR S768_D770dup", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31208370"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27959700", "25923549", "26720284", "24893891", "26515464"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Squamous Cell Carcinoma", "pmids": ["37641467"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["26269204"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29386539"]}, {"variant_name": "EGFR T790M AND EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27959700"]}, {"variant_name": "EGFR T790M AND EGFR Exon 19 Deletion", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["26181354"]}, {"variant_name": "EGFR T790M AND EGFR Exon 19 Deletion AND EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["26181354"]}, {"variant_name": "EGFR T790M AND EGFR Exon 19 Deletion AND MET Splice Site (c.3027_3028+21delAGGTATATTTCAGTTTATTGTTC", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["38074875"]}, {"variant_name": "ERBB2 L755P", "gene_symbol": "ERBB2", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["37197637"]}], "error": null}
{"id": "F5.2-000012-S1-P3", "question": "List treatments supported by variant evidence in B-ALL With IAMP21.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'b-lymphoblastic' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia/lymphoma' AND\n    toLower(rel.disease_name) CONTAINS 'with' AND\n    toLower(rel.disease_name) CONTAINS 'iamp21'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n", "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('IAMP21')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('IAMP21'))\n)\nAND toLower(rel.disease_name) CONTAINS toLower('B-ALL')\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Variant THEN coalesce(b.name, b.hgvs_p) ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL OR variant_name IS NOT NULL\nRETURN\n  variant_name,\n  gene_symbol,\n  therapy_name,\n  effect,\n  disease_name,\n  pmids\nLIMIT 100", "gold_rows": [{"variant_name": "ZC3HAV1 ZC3HAV1::ABL2 Fusion", "gene_symbol": "ZC3HAV1", "therapy_name": "Asciminib", "effect": "sensitivity", "disease_name": "B-lymphoblastic Leukemia/lymphoma With IAMP21", "pmids": ["40678005"]}, {"variant_name": "ZC3HAV1 ZC3HAV1::ABL2 Fusion", "gene_symbol": "ZC3HAV1", "therapy_name": "BCR-ABL Inhibitor HS-10382", "effect": "sensitivity", "disease_name": "B-lymphoblastic Leukemia/lymphoma With IAMP21", "pmids": ["40678005"]}], "generated_rows": [], "error": null}
